Prophylactic effect of colchincine and amiodarone
Phase 2
- Conditions
- Cardiology
- Registration Number
- PACTR202101651961317
- Lead Sponsor
- Tanta university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
•Patients undergoing elective coronary artery bypass surgery
Exclusion Criteria
• Emergency CABG.
•Patients with chronic renal failure as diagnosed by serum creatinine level above 200µmol/l.
•Patient undergoing CABG combined with valve surgery.
•Patients undergoing Re-Do CABG.
•Patients with history of atrial fibrillation determined by previous records.
• Patients with known hypersensitivity-allergy to colchicine or amiodarone.
•Under chronic treatment with colchicine or amiodarone.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method evaluation preventive role of colchicine and amiodarone against atrial fibrillation after coronary artery bypass grafting. <br>
- Secondary Outcome Measures
Name Time Method effect on Intensive care stay and hospital stay